How Peptide Therapy Works

Peptide therapy refers to the clinical use of short amino acid chains — peptides — that interact with specific receptors in the body to influence biological processes. The appeal of peptides in clinical contexts stems from their specificity: different peptides target different pathways, allowing clinicians to design protocols aimed at particular goals such as recovery, hormone optimisation, weight management, or longevity.

Peptides work by binding to receptors on cell surfaces or within cells, triggering downstream signalling cascades that influence gene expression, hormone release, tissue repair, metabolism, or immune function depending on the peptide and receptor involved. Because they are short chains of amino acids, they are generally broken down by the body relatively quickly compared to larger proteins or synthetic drugs.

Administration routes vary by peptide and protocol. Many are delivered by subcutaneous injection, which allows for more predictable absorption than oral administration, since peptides are typically degraded in the digestive tract before reaching systemic circulation. Some peptides are available in oral, topical, or intranasal formats, though these are less common in clinical settings.

The clinical evidence base varies significantly across different peptides. GLP-1 drugs like semaglutide and tirzepatide have large, well-funded trial programmes and regulatory approval for specific indications. Others, such as BPC-157 or certain growth hormone secretagogues, have more limited human evidence, often relying on preclinical or small-scale studies.

A reputable clinic offering peptide therapy should be able to explain the mechanism of action of any proposed treatment, the quality of the evidence base, the regulatory status in your jurisdiction, and what monitoring will be conducted throughout the protocol.

This page is informational only. Peptide Clinic Finder is a directory and does not provide medical advice or prescribe treatments.